Dear Health Care providers,
It is my great pleasure to invite all of you to participate in the Annual Breast Cancer Conference 2023.
This year's conference theme is "Bench to Bedside: Research is the Driver for a Paradigm Shift of Clinical Practice in Breast Cancer Management".
The concept of "bench to bedside" describes the process of taking research results from the laboratory into the clinic, so they can directly benefit patients.
It is fundamental in the new era of cancer treatment with different targeted therapy, immunotherapy, and Antibody Drug conjugates. Almost all the newly discovered drugs for treating breast cancer in various settings have been achieved through this process.
Therefore, this year's Breast Cancer Conference aims to update our knowledge and clinical practices, and bring together clinicians, nurses, laboratory experts, and researchers across the institution to understand better translational research in breast cancer and novel medication development (from Bench to bedside).
The conference program will focus on and discuss the most recent research data published in 2023 and consider practice changes in managing breast cancer.
The conference will also be an excellent platform for comprehensive summaries delivered by well-known international, regional, and local keynote speakers on breast cancer.
These speakers will eagerly provide the most Up-To-Date scientific reviews on biology, biomarkers, and alike. Attendees will also highlight topics of great interest for surgeons, medical and radiation oncologists, pathologists, primary care physicians, and nurses.
We anticipate 300 delegates will attend this conference with our distinguished faculty members. We look forward to welcoming you to this special event.
Dr. Salha Bujassoum
Chair of Organizing Committee - Annual Breast Cancer Conference 2023
Chairperson of Medical Oncology and Palliative Medicine - NCCCR
Clinical Leads of Breast Cancer at NCCCR and Director of Cancer Genetics